The antimicrobial and cell-penetrating effects of the CPP penetratin and derived analogues.

Research output: Contribution to conferencePosterResearch

Standard

The antimicrobial and cell-penetrating effects of the CPP penetratin and derived analogues. / Bahnsen, Jesper Søborg; Franzyk, Henrik; Nielsen, Hanne Mørck.

2012. Poster session presented at Zing Peptide Therapeutics Conference, 2012, Lanzarote, Spain.

Research output: Contribution to conferencePosterResearch

Harvard

Bahnsen, JS, Franzyk, H & Nielsen, HM 2012, 'The antimicrobial and cell-penetrating effects of the CPP penetratin and derived analogues.', Zing Peptide Therapeutics Conference, 2012, Lanzarote, Spain, 12/02/2012.

APA

Bahnsen, J. S., Franzyk, H., & Nielsen, H. M. (2012). The antimicrobial and cell-penetrating effects of the CPP penetratin and derived analogues.. Poster session presented at Zing Peptide Therapeutics Conference, 2012, Lanzarote, Spain.

Vancouver

Bahnsen JS, Franzyk H, Nielsen HM. The antimicrobial and cell-penetrating effects of the CPP penetratin and derived analogues.. 2012. Poster session presented at Zing Peptide Therapeutics Conference, 2012, Lanzarote, Spain.

Author

Bahnsen, Jesper Søborg ; Franzyk, Henrik ; Nielsen, Hanne Mørck. / The antimicrobial and cell-penetrating effects of the CPP penetratin and derived analogues. Poster session presented at Zing Peptide Therapeutics Conference, 2012, Lanzarote, Spain.

Bibtex

@conference{b862905dc0a4443291dfb3e3ffac6609,
title = "The antimicrobial and cell-penetrating effects of the CPP penetratin and derived analogues.",
author = "Bahnsen, {Jesper S{\o}borg} and Henrik Franzyk and Nielsen, {Hanne M{\o}rck}",
year = "2012",
language = "English",
note = "Zing Peptide Therapeutics Conference, 2012 ; Conference date: 12-02-2012",

}

RIS

TY - CONF

T1 - The antimicrobial and cell-penetrating effects of the CPP penetratin and derived analogues.

AU - Bahnsen, Jesper Søborg

AU - Franzyk, Henrik

AU - Nielsen, Hanne Mørck

PY - 2012

Y1 - 2012

M3 - Poster

T2 - Zing Peptide Therapeutics Conference, 2012

Y2 - 12 February 2012

ER -

ID: 147217296